Kumar S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut 2022 Jan 24. pii: gutjnl-2021-324834. doi: 10.1136/gutjnl-2021-324834.
PMID: 35074907